4//SEC Filing
Doyle Ramona 4
Accession 0001209191-21-028028
CIK 0001601830other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 7:53 PM ET
Size
10.6 KB
Accession
0001209191-21-028028
Insider Transaction Report
Form 4
Doyle Ramona
Chief Medical Officer
Transactions
- Conversion
Stock Option (Right to Buy)
2021-04-20−750,000→ 0 totalExercise: $2.47Exp: 2030-12-30→ Common Stock (750,000 underlying) - Conversion
Stock Option (Right to Buy)
2021-04-20+750,000→ 750,000 totalExercise: $2.47Exp: 2030-12-30→ Class A Common Stock (750,000 underlying)
Footnotes (2)
- [F1]Twenty-Five percent (25%) of the shares subject to the award shall vest one year after December 31, 2020, or the Vesting Commencement Date, and one-forty-eighth (148th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.
- [F2]Pursuant to a reclassification exempt under Rule 16b-7, each share of Common Stock was automatically reclassified into one share of Class A Common Stock immediately prior to the completion of the Issuer's IPO.
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001856069
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 7:53 PM ET
- Size
- 10.6 KB